173 related articles for article (PubMed ID: 30902552)
1. Effective Dose of Landiolol, an Ultra-Short-Acting β-Blocker, to Decrease Heart Rate During On-Pump, Beating Coronary Artery Bypass Grafting.
Kawashima S; Kurita T; Morita K; Nakajima Y
J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2195-2200. PubMed ID: 30902552
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
Shimomura T; Fujii G; Suzuki S; Miyahara K; Matsuura A; Yoshida K; Kasamatsu M
Kyobu Geka; 2004 Mar; 57(3):229-32. PubMed ID: 15035081
[TBL] [Abstract][Full Text] [Related]
3. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
[TBL] [Abstract][Full Text] [Related]
4. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
Fujii M; Bessho R; Ochi M; Shimizu K; Terajima K; Takeda S
J Cardiovasc Surg (Torino); 2012 Jun; 53(3):369-74. PubMed ID: 22249647
[TBL] [Abstract][Full Text] [Related]
5. Landiolol reduces coronary artery motion in an open-chest porcine model: implications for off-pump coronary artery bypass surgery.
Wakamatsu H; Watanabe T; Sato Y; Takase S; Omata S; Yokoyama H
Surg Today; 2012 Jan; 42(2):205-8. PubMed ID: 22105530
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
[TBL] [Abstract][Full Text] [Related]
7. Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.
Osumi M; Tashiro T; Morita Y; Kamiya S; Minematsu N; Nishimi M; Wada H
Adv Ther; 2014 Oct; 31(10):1109-17. PubMed ID: 25319249
[TBL] [Abstract][Full Text] [Related]
8. Perioperative use of a beta blocker in coronary artery bypass grafting.
Ogawa S; Okawa Y; Goto Y; Aoki M; Baba H
Asian Cardiovasc Thorac Ann; 2013 Jun; 21(3):265-9. PubMed ID: 24570490
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose landiolol, an ultrashort-acting beta-blocker, on postoperative atrial fibrillation after CABG surgery.
Fujiwara H; Sakurai M; Namai A; Kawamura T
Gen Thorac Cardiovasc Surg; 2009 Mar; 57(3):132-7. PubMed ID: 19280308
[TBL] [Abstract][Full Text] [Related]
10. [Effect of intra-operative low-dose infusion of landiolol hydrochloride on post-operative atrial fibrillation after off-pump coronary artery bypass grafting].
Wakamatsu H; Takase S; Sato Y; Seto Y; Kurosawa H; Yokoyama H
Kyobu Geka; 2010 Aug; 63(9):764-8. PubMed ID: 20715455
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
Taenaka N; Kikawa S
Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
Ito N; Tashiro T; Morishige N; Nishimi M; Hayashida Y; Minematsu N; Kuwahara G; Sukehiro Y; Teratani H
Heart Surg Forum; 2012 Aug; 15(4):E189-94. PubMed ID: 22917822
[TBL] [Abstract][Full Text] [Related]
13. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
[TBL] [Abstract][Full Text] [Related]
14. [Effect of landiolol and combined use of landiolol and olprinone on hemodynamics in patients undergoing off-pump coronary artery bypass grafting].
Tachikawa M; Shimazaki M; Arai T; Saima S; Adachi E; Okuda Y
Masui; 2012 Jun; 61(6):566-73. PubMed ID: 22746016
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Sezai A; Nakai T; Hata M; Yoshitake I; Shiono M; Kunimoto S; Hirayama A
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1241-8. PubMed ID: 22858430
[TBL] [Abstract][Full Text] [Related]
16. The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.
Goto K; Hagiwara S; Hidaka S; Yamamoto S; Kusaka J; Yasuda N; Shingu C; Noguchi T
J Anesth; 2010 Feb; 24(1):11-6. PubMed ID: 20052497
[TBL] [Abstract][Full Text] [Related]
17. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults.
Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J
BMC Pharmacol Toxicol; 2020 Nov; 21(1):82. PubMed ID: 33239108
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
Takahata T; Yasui-Furukori N; Sakamoto J; Suto K; Suto T; Tateishi T; Munakata A
Drugs R D; 2005; 6(6):385-94. PubMed ID: 16274261
[TBL] [Abstract][Full Text] [Related]
20. Use of low-dose β
Sakai M; Jujo S; Kobayashi J; Ohnishi Y; Kamei M
J Cardiothorac Surg; 2019 Jul; 14(1):145. PubMed ID: 31345252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
